Stock DNA
Pharmaceuticals & Biotechnology
CNY 4,719 Million (Mid Cap)
25.00
NA
0.00%
-0.83
6.86%
1.58
Revenue and Profits:
Net Sales:
275 Million
(Quarterly Results - Jun 2025)
Net Profit:
61 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.02%
0%
-9.02%
6 Months
-10.9%
0%
-10.9%
1 Year
27.94%
0%
27.94%
2 Years
11.86%
0%
11.86%
3 Years
-49.41%
0%
-49.41%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
BMC Medical Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-19.91%
EBIT Growth (5y)
-48.92%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.86
Sales to Capital Employed (avg)
0.35
Tax Ratio
9.84%
Dividend Payout Ratio
22.89%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
116.75%
ROE (avg)
9.36%
Valuation key factors
Factor
Value
P/E Ratio
25
Industry P/E
Price to Book Value
1.61
EV to EBIT
16.12
EV to EBITDA
13.43
EV to Capital Employed
5.13
EV to Sales
2.24
PEG Ratio
0.96
Dividend Yield
NA
ROCE (Latest)
31.85%
ROE (Latest)
6.38%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
275.10
188.90
45.63%
Operating Profit (PBDIT) excl Other Income
61.80
24.50
152.24%
Interest
1.70
0.30
466.67%
Exceptional Items
-0.60
0.00
Consolidate Net Profit
60.80
43.20
40.74%
Operating Profit Margin (Excl OI)
199.10%
94.90%
10.42%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 45.63% vs -28.64% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 40.74% vs -51.35% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
835.70
1,116.00
-25.12%
Operating Profit (PBDIT) excl Other Income
119.50
258.60
-53.79%
Interest
3.30
1.70
94.12%
Exceptional Items
7.50
0.10
7,400.00%
Consolidate Net Profit
158.60
299.80
-47.10%
Operating Profit Margin (Excl OI)
110.80%
210.80%
-10.00%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -25.12% vs -20.67% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -47.10% vs -21.31% in Dec 2023
About BMC Medical Co. Ltd. 
BMC Medical Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






